The novel approach of the medication represents a significant development in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide799193.thezenweb.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-80878966